Natixis is committed to cancer research
© Gustave Roussy
Since 2011, Natixis has supported the Gustave Roussy Foundation with its cancer research. After supporting three research teams working on personalized cancer treatments, Natixis once again pledged its support in 2016 for 3 years, by offering financial support to three new research teams for their work in precision medicine and fundamental research.
Natixis supports the Gustave Roussy Foundation
The financial support given by Natixis to the Gustave Roussy Center, France’s leading cancer research center, helps researchers acquire new skills and advance their research into personalized cancer protocols.
Standard treatments are not effective with all patients, which can result in a therapeutic stalemate. Personalized cancer medicine provides real hope to these people. More specifically, this approach takes into account the patient’s individual characteristics and the tumour’s genomic data so that the treatment can be adapted to the patient.
Our actions over the past 3 years – 2016-2018
Since 2016 Natixis has supported three new research teams at the Gustave Roussy Cancer Research Center. The first team is working on a therapeutic trial while the other two are working on fundamental research in two promising oncology fields: immunology and DNA repair.
Eric Solary, Director of Research at Gustave Roussy, and doctors Luc Friboulet, Sébastien Apcher and Gérard Mazon talk about the work they have performed over the past three years together with their research teams.
The three Natixis research teams – 2016-2018
• Team led by Professors Jean-Charles Soria and Fabrice André: MATCH-R trial to understand resistance to new treatments
• Team led by Sébastien Apcher on tumour immunology and immunotherapy against cancer
• Team led by Gérard Mazon on the repair mechanisms of DNA double-strands breaks
Our actions over the past 5 years – 2011-2015
Well aware of the great cost involved in advancing cancer research, Natixis decided at the end of 2011 to support the Gustave Roussy Foundation. Natixis helps three research teams carry out their research work. The partnership is part of the research program into personalized medicine called “Revolution Cancer”.
Fanny Jaulin, Jean-Luc Perfettini and Medhi Khaled, who head up the three teams that Natixis supports, talk about the work they have performed over the past few years.
The three Natixis research teams – 2011-2015
• Team researching cell death and senescence headed by Jean-Luc Perfettini
• Team researching epithelial morphogenesis and colon cancer headed by Fanny Faulin
• Team researching melanoma and tumor invasion headed by Mehdi Khaled
Natixis’ commitment is shared by its employees
Natixis’ commitment is also shared by its employees who for many years have taken part in the Odysséa charity race.
The race entry fees are donated to the Gustave Roussy Center to advance breast cancer research.
Natixis also organizes a range of actions for employees such as conferences, quizzes and events that attract a great turnout.
The Gustave Roussy Foundation was created in 2005 to fund cancer research conducted at the Gustave Roussy Cancer Center. Its overriding mission is to improve the quality of care and the life of patients treated there.
For over 90 years, the Gustave Roussy Center, France’s leading cancer research center, has been on the cutting edge of international innovation in the fight against cancer. Its research, treatment and training focus on patients fighting cancer. The Gustave Roussy Center treats cancer sufferers of all ages and at every stage of the illness.